MGP Ingredients (MGPI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
14 Mar, 2026Executive summary
Q2 2025 results showed sequential improvement across all business segments, with consolidated sales down 24% year-over-year to $145.5 million and execution largely in line with expectations.
Premium Plus branded spirits portfolio continued to show strength, while Ingredient Solutions rebounded year-over-year.
Net income for Q2 2025 was $14.4 million, down 55% from the prior year; adjusted EPS declined 43% to $0.97.
New CEO Julie Francis appointed, bringing a growth mindset and focus on operational excellence.
Financial highlights
Consolidated sales declined 24% to $145.5 million; adjusted EBITDA fell 38% to $35.9 million; gross margin dropped 350 bps to 40.1%.
Branded Spirits sales declined 5%, but Premium Plus sales grew 1%; Distilling Solutions sales fell 46% mainly due to a 54% drop in brown goods; Ingredient Solutions sales increased 5%.
Net income dropped to $14.4 million; adjusted net income was $20.9 million; operating cash flow YTD rose to $56.4 million.
Capital expenditures for 2025 projected at $32.5 million; cash balance at June 30, 2025 was $17.3 million.
Outlook and guidance
Full-year 2025 guidance reaffirmed: net sales $520–$540 million, adjusted EBITDA $105–$115 million, adjusted EPS $2.45–$2.75, and capital expenditures at $32.5 million.
Premium Plus sales expected to grow low single digits for the year; mid and value tier brands projected to decline low double digits.
Branded Spirits segment gross margins expected in the upper 40% to low 50% range.
Latest events from MGP Ingredients
- Premium spirits growth and record margins offset Atchison closure; outlook reaffirmed.MGPI
Q2 202414 Mar 2026 - Q1 sales fell 29% and net loss hit $3.1M, but premium brands grew and guidance was reaffirmed.MGPI
Q1 202514 Mar 2026 - 2025 outlook signals branded spirits-led growth amid whiskey headwinds and cost reductions.MGPI
Q4 202414 Mar 2026 - Q3 sales dropped 24% but net income surged 82% on margin gains and cost controls.MGPI
Q3 202414 Mar 2026 - 2025 saw profit declines from impairment and weak brown goods, but record cash flow and premium brand gains.MGPI
Q4 202525 Feb 2026 - Board elections, auditor ratification, and executive pay are key 2025 proxy issues, with strong governance focus.MGPI
Proxy Filing1 Dec 2025 - Jennifer Lowry is nominated as a Group B director, to be elected solely by preferred stockholders.MGPI
Proxy Filing1 Dec 2025 - Sales and profits fell, but premium brands grew and guidance was raised for 2025.MGPI
Q3 202530 Oct 2025